SMARCA4-deficient Undifferentiated Thoracic Tumor That Responded to Pembrolizumab Monotherapy in a Patient with a Poor Performance Status

Authors

Institutions

Publication Details

Journal
Haigan
Published
2025-06-20
DOI
https://doi.org/10.2482/haigan.65.175
Primary Topic
Peptidase Inhibition and Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SMARCA4-deficient Undifferentiated Thoracic Tumor That Responded to Pembrolizumab Monotherapy in a Patient with a Poor Performance Status

Yoshiaki Zaizen, Kenji Tsumura, Koichi Azuma, Tomoaki Hoshino et al.
Haigan
Peptidase Inhibition and Analysis
article

SMARCA4-deficient Undifferentiated Thoracic Tumor That Responded to Pembrolizumab Monotherapy in a Patient with a Poor Performance Status

Yoshiaki Zaizen, Kenji Tsumura, Koichi Azuma, Tomoaki Hoshino, Yoshihisa Tokunaga, Tomohiro Tanaka, Daiki Murata
article en

Abstract

No abstract available for this paper.
HaiganVol. 65(3)
Kurume University (JP)
No poverty
Openalex Percentile: Top 77%
Peptidase Inhibition and Analysis
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.